Silicon Laboratories, Inc. (NASDAQ:SLAB) Receives $167.78 Consensus Price Target from Brokerages

Shares of Silicon Laboratories, Inc. (NASDAQ:SLAB) have earned a consensus rating of “Hold” from the ten research firms that are currently covering the company, Marketbeat.com reports. One investment analyst has rated the stock with a sell recommendation, eight have issued a hold recommendation and one has assigned a buy recommendation to the company. The average 12 month price target among brokers that have covered the stock in the last year is $167.7778.

A number of analysts have recently weighed in on the stock. Benchmark downgraded shares of Silicon Laboratories from a “buy” rating to a “hold” rating in a report on Wednesday, February 4th. KeyCorp cut Silicon Laboratories from an “overweight” rating to a “hold” rating in a research note on Wednesday, February 4th. Weiss Ratings restated a “sell (d-)” rating on shares of Silicon Laboratories in a research report on Monday, December 29th. Royal Bank Of Canada lifted their target price on Silicon Laboratories from $160.00 to $205.00 and gave the stock a “sector perform” rating in a report on Thursday, February 5th. Finally, Needham & Company LLC lowered Silicon Laboratories from a “buy” rating to a “hold” rating in a report on Wednesday, February 4th.

Silicon Laboratories Stock Up 0.3%

Shares of SLAB stock opened at $204.72 on Friday. The stock has a market cap of $6.75 billion, a P/E ratio of -102.87 and a beta of 1.56. The company’s fifty day simple moving average is $163.32 and its two-hundred day simple moving average is $143.11. Silicon Laboratories has a 52 week low of $82.82 and a 52 week high of $208.84.

Silicon Laboratories (NASDAQ:SLAB) last announced its quarterly earnings results on Wednesday, February 4th. The semiconductor company reported $0.56 earnings per share for the quarter, topping the consensus estimate of $0.54 by $0.02. The company had revenue of $208.21 million for the quarter, compared to analysts’ expectations of $207.63 million. Silicon Laboratories had a negative net margin of 8.27% and a negative return on equity of 4.07%. Silicon Laboratories’s quarterly revenue was up 25.3% on a year-over-year basis. During the same quarter in the previous year, the business posted ($0.11) earnings per share. On average, analysts anticipate that Silicon Laboratories will post -0.97 EPS for the current fiscal year.

Insiders Place Their Bets

In related news, SVP Brandon Tolany sold 4,246 shares of the company’s stock in a transaction dated Thursday, December 4th. The shares were sold at an average price of $140.17, for a total transaction of $595,161.82. Following the transaction, the senior vice president directly owned 62,381 shares in the company, valued at approximately $8,743,944.77. This represents a 6.37% decrease in their position. The sale was disclosed in a document filed with the SEC, which is accessible through this hyperlink. Also, Director Nina Richardson sold 1,355 shares of the firm’s stock in a transaction dated Tuesday, January 13th. The stock was sold at an average price of $149.00, for a total transaction of $201,895.00. Following the completion of the sale, the director directly owned 8,543 shares of the company’s stock, valued at approximately $1,272,907. The trade was a 13.69% decrease in their position. Additional details regarding this sale are available in the official SEC disclosure. Insiders have sold 7,555 shares of company stock worth $1,073,528 in the last quarter. Company insiders own 1.60% of the company’s stock.

Institutional Investors Weigh In On Silicon Laboratories

Several hedge funds and other institutional investors have recently modified their holdings of the business. Vident Advisory LLC boosted its holdings in Silicon Laboratories by 2.5% during the 4th quarter. Vident Advisory LLC now owns 3,018 shares of the semiconductor company’s stock valued at $394,000 after acquiring an additional 74 shares during the period. UMB Bank n.a. lifted its position in shares of Silicon Laboratories by 43.9% during the third quarter. UMB Bank n.a. now owns 282 shares of the semiconductor company’s stock worth $37,000 after purchasing an additional 86 shares during the last quarter. EverSource Wealth Advisors LLC boosted its stake in shares of Silicon Laboratories by 45.7% during the third quarter. EverSource Wealth Advisors LLC now owns 274 shares of the semiconductor company’s stock valued at $36,000 after purchasing an additional 86 shares during the period. Bank of Montreal Can grew its holdings in shares of Silicon Laboratories by 2.9% in the fourth quarter. Bank of Montreal Can now owns 3,355 shares of the semiconductor company’s stock worth $438,000 after purchasing an additional 96 shares during the last quarter. Finally, Inspire Investing LLC grew its holdings in shares of Silicon Laboratories by 3.1% in the fourth quarter. Inspire Investing LLC now owns 3,585 shares of the semiconductor company’s stock worth $469,000 after purchasing an additional 109 shares during the last quarter.

Silicon Laboratories Company Profile

Silicon Laboratories (NASDAQ:SLAB) is a global semiconductor company that develops high-performance analog and mixed-signal integrated circuits, wireless system-on-chips (SoCs), microcontrollers, and radio frequency (RF) solutions. Its product portfolio is tailored to support the Internet of Things (IoT), infrastructure, industrial automation, consumer electronics, automotive, and energy markets. By combining silicon, software, and tools, Silicon Labs aims to accelerate development cycles and deliver low-power, highly integrated solutions that address demanding application requirements.

Founded in 1996 and headquartered in Austin, Texas, Silicon Labs has grown into a multinational organization with engineering and sales operations across North America, Europe, and Asia.